MC 4262
Alternative Names: MC 1/Angiotensin Receptor Blocker; MC 1/ARB; Pyridoxal phosphate/Angiotensin Receptor BlockerLatest Information Update: 18 Aug 2014
At a glance
- Originator Medicure
- Class Antihypertensives; Ischaemic heart disorder therapies; Picolines
- Mechanism of Action Angiotensin receptor antagonists; Purinergic P2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension; Metabolic syndrome
Most Recent Events
- 18 Aug 2014 Discontinued - Phase-I for Hypertension in Canada (PO)
- 18 Aug 2014 Discontinued - Phase-I for Metabolic syndrome in Canada (PO)
- 12 May 2005 Phase-I clinical trials in Hypertension in Canada (unspecified route)